Gastrointestinal Therapeutics and Diagnostics Market
Gastrointestinal Therapeutics and Diagnostics
Market Scope: Industry Analysis, Market Size,
Growth, Trends Till 2031
Request Sample Report
Gastrointestinal Therapeutics and Diagnostics Market Size and Growth
The Gastrointestinal Therapeutics and Diagnostics market is experiencing substantial growth, driven by rising prevalence of gastrointestinal disorders and advancements in technologies. The market size is projected to reach USD 55 billion by 2026, fueled by innovative treatment modalities and increasing demand for diagnostic tools. Strong investment in research enhances market dynamics.
Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Abbott Laboratories
◍ AstraZeneca
◍ Eisai
◍ Johnson & Johnson
◍ Salix Pharmaceuticals
◍ Takeda Pharmaceutical Company
The gastrointestinal therapeutics and diagnostics market features major players like Abbott Laboratories, AstraZeneca, Eisai, Johnson & Johnson, Salix Pharmaceuticals, and Takeda Pharmaceutical Company. These companies drive market growth through innovative therapies, advanced diagnostics, and strategic partnerships. Sales revenues include Abbott: $43 billion, AstraZeneca: $37 billion, and Johnson & Johnson: $95 billion.
Request Sample Report
Market Segmentation
By Application
Gastroenteritis
◍ GI Bleeding
◍ Irritable Bowel Syndrome
◍ Peptic Ulcer Disease (PUD) ◍ Others Request Sample Report
By Product
Diagnostics
Therapeutics
Market Growth
Request Sample Report
$ X Billion USD
